Health Care
- Cost Estimate
S. 142, Preserve Access to Affordable Generics and Biosimilars Act
As reported by the Senate Committee on the Judiciary on March 1, 2023
- Cost Estimate
S. 148, Stop STALLING Act
As reported by the Senate Committee on the Judiciary on March 1, 2023
- Cost Estimate
H.R. 3391, Gabriella Miller Kids First Research Act 2.0
As passed by the House of Representatives on March 5, 2024
- Report
Answers to Questions for the Record Following a Hearing on the Oversight of CBO
The House Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified about the work of CBO. This document provides CBO’s answers to questions submitted for the record.
- Presentation
CBO’s Approach to Estimating the Budgetary Effects of the No Surprises Act of 2021
Presentation by Daria Pelech, an analyst in CBO’s Health Analysis Division, at the Center for Health Insurance Reform McCourt School of Public Policy, Georgetown University.
- Cost Estimate
H.R. 766, Dr. Michael C. Burgess Preventive Health Savings Act
As ordered reported by the House Committee on the Budget on February 6, 2024
- Report
The Budget and Economic Outlook: 2024 to 2034
In CBO’s projections, federal budget deficits total $20 trillion over the 2025–2034 period and federal debt held by the public reaches 116 percent of GDP. Economic growth slows to 1.5 percent in 2024 and then continues at a moderate pace.
- Cost Estimate
S. 2840, Bipartisan Primary Care and Health Workforce Act
As reported by the Senate Committee on Health, Education, Labor, and Pensions on November 8, 2023
- Report
Testimony on Federal Subsidies for Health Insurance and Policies to Reduce the Prices Paid by Commercial Insurers
Chapin White, CBO's Director of Health Analysis, testifies before the House Energy and Commerce Committee's Subcommittee on Health.
- Cost Estimate
S. 1573, PREEMIE Reauthorization Act of 2023
As reported by the Senate Committee on Health, Education, Labor, and Pensions on October 4, 2023